Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.

MLA

McDonald, Emily G., et al. “Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium Difficile Infection.” JAMA Internal Medicine, vol. 175, no. 5, May 2015, pp. 784–91. EBSCOhost, https://doi.org/10.1001/jamainternmed.2015.42.

APA

McDonald, E. G., Milligan, J., Frenette, C., & Lee, T. C. (2015). Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection. JAMA Internal Medicine, 175(5), 784–791. https://doi.org/10.1001/jamainternmed.2015.42

Chicago

McDonald, Emily G, Jonathon Milligan, Charles Frenette, and Todd C Lee. 2015. “Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium Difficile Infection.” JAMA Internal Medicine 175 (5): 784–91. doi:10.1001/jamainternmed.2015.42.